Jim Tanabaum As A Participant In The Development Of Health Care

Mindstrong Health, a forum that raised $ 14 million dollars for neuropsychiatric treatment and diagnosis; http://www.massdevice.com/neuropsych-treatment-diagnosis-platform-dev-mindstrong-health-raises-14m-series/. This forum is used to monitor brain function using smartphone devices. The smartphone device detects and carefully follows moods, memory, attention, and other primary functions. According to the executive of Mindstrong Health, this approach is used to analyze, and it set a pace for future inventions that aim at enhancing mental health. Smartphones can now be a new found technique of resolving mental problems.

The foundation’s team brings together different people with different experiences, approaches, and leadership to come up with ways of enhancing medical care for patients who have mental conditions. Jim Tanabaum addressed the trial report release in the coming month. He also expressed his confidence in modern medicine which is determined by objective measurements unlike previously when neuropsychiatric analysis used subjective reports. Mindstrong health is obligated to provide objective measures to the mental cases just like in that of other terminal diseases.

Jim Tanabaum is the re-known founder and CEO of Foresite Capital; a health care firm put up in 2011 that enumerates in recognition of emerging health leaders and assists the growth of the health leaders through capital networks supply. Initially, Jim ventured into several companies that grew into health franchises as a co-investor. Jim Tanabaum is an academic who is always motivated to find solutions and thrives on going where passion lies. He encourages risk taking as long as one has thought through the aspect at risk.

Currently, Jim’s largest investment is Intarica; a twice year type II diabetes that assists patients with weight loss and control of the disease that is now estimated to affect 350 million people globally as well as Glaucoma which is a once daily treatment from his investment in Aeri pharmaceuticals. Glaucoma is said to affect 40 million people globally causing blindness. Jim Tanabaum is passionate about academics evident through his pursuit of knowledge. The entrepreneur holds both a B.S and B.S.E.E from Yale University and an MD from Harvard Medical School. He also received from his MBA and MS from Harvard University and MIT respectively.

Source: crunchbase.com